Cargando…
HLA-DQ antibodies in alloimmunity, what makes them different?
PURPOSE OF REVIEW: De novo HLA-DQ antibodies are the most frequently observed after solid-organ allotransplantation; and are associated with the worse adverse graft outcomes compared with all other HLA antibodies. However, the biological explanation for this observation is not yet known. Herein, we...
Autores principales: | Meneghini, Maria, Tambur, Anat R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487393/ https://www.ncbi.nlm.nih.gov/pubmed/37219535 http://dx.doi.org/10.1097/MOT.0000000000001079 |
Ejemplares similares
-
Antibody-mediated rejection: prevention, monitoring and treatment dilemmas
por: Rodriguez-Ramirez, Sonia, et al.
Publicado: (2022) -
HLA‐DR/DQ molecular mismatch: A prognostic biomarker for primary alloimmunity
por: Wiebe, Chris, et al.
Publicado: (2018) -
HLA Alleles Cw12 and DQ4 in Kidney Transplant Recipients Are Independent Risk Factors for the Development of Posttransplantation Diabetes
por: Phagura, Nuvreen, et al.
Publicado: (2021) -
Single-port splenectomy: Current update and controversies
por: Targarona, Eduardo M, et al.
Publicado: (2011) -
Single-incision laparoscopic splenectomy
por: Joshi, Manish, et al.
Publicado: (2011)